Our Research Publications
Updated November 2023
Pagination
- Previous page
- Page 4
- Next page
Title | Authors | Year Sort descending | Journal | Link to Article | Intended Audience | Purpose |
---|---|---|---|---|---|---|
Platelet antibodies and fetal growth: maternal antibodies against fetal platelet antigen 1a are strongly associated with reduced birthweight in boys | Tiller H, Killie MK, Husebekk A, Skogen B, Ni H, Kjeldsen-Kragh J, Olan P | 2012 | Acta Obstet Gyn Scan | View Platelet antibodies and fetal growth: maternal antibodies against fetal platelet antigen 1a are strongly associated with reduced birthweight in boys | Health care providers | Clinical research |
Riboflavin and ultraviolet light treatment potentiates vasodilator-stimulated phosphoprotein Ser-239 phosphorylation in platelet concentrates during storage | Schubert P, Culibrk B, Coupland D, Scammell K, Gyongyossy-Issa M, Devine DV | 2012 | Transfusion | View Riboflavin and ultraviolet light treatment potentiates vasodilator-stimulated phosphoprotein Ser-239 phosphorylation in platelet concentrates during storage | Researchers | Basic research |
Donor motivation in Xi'an, China: comparison with Canadian donors | O'Brien SF, Shao ZJ, Osmond L, Yi QL, Li CY, An QX | 2012 | Vox Sang | View Donor motivation in Xi'an, China: comparison with Canadian donors | Blood operators | Other |
Herpesviruses enhance fibrin clot lysis | Gershom ES, Vanden Hoek AL, Meixner SC, Sutherland MR, Pryzdial EL | 2012 | Thromb Haemost | View Herpesviruses enhance fibrin clot lysis | Researchers | Basic research |
Kruppel-like factor 1 (KLF1), KLF2, and Myc control a regulatory network essential for embryonic erythropoiesis | Pang CJ, Lemsaddek W, Alhashem YN, Bondzi C, Redmond LC, Ah-Son N, Dumur CI, Archer KJ, Haar JL, Lloyd JA, Trudel M | 2012 | Mol Cell Biol | View Kruppel-like factor 1 (KLF1), KLF2, and Myc control a regulatory network essential for embryonic erythropoiesis | Researchers | Basic research |
Measures to prevent transfusion-related acute lung injury (TRALI) | Reesink HW, Lee J, Keller A, Dennington P, Pink J, Holdsworth R, Schennach H, Goldman M, Petraszko T, Sun J, Meng Y, Qian K, Rehacek V, Turek P, Krusius T, Juvonen E, Tiberghien P, Legrand D, Semana G, Muller JY, Bux J, Reil A, Lin CK, Daly H, McSweeney E, Porretti L, Greppi N, Rebulla P, Okazaki H, Sanchez-Guerrero SA, Baptista-Gonzalez HA, Martinez-Murillo C, Guerra-Marquez A, Rodriguez-Moyado H, Middelburg RA, Wiersum-Osselton JC, Brand A, van Tilburg C, Dinesh D, Dagger J, Dunn P, Brojer E, Letowska M, Maslanka K, Lachert E, Uhrynowska M, Zhiburt E, Palfi M, Berlin G, Frey BM, Puig Rovira L, Muniz-Diaz E, Castro E, Chapman C, Green A, Massey E, Win N, Williamson L, Silliman CC, Chaffin DJ, Ambruso DR, Blumberg N, Tomasulo P, Land KJ, Norris PJ, Illoh OC, Davey RJ, Benjamin RJ, Eder AF, McLaughlin L, Kleinman S, Panzer S | 2012 | Vox Sang | View Measures to prevent transfusion-related acute lung injury (TRALI) | Blood operators | Benchmarking and standard setting |
Lessons learned from Trypanosoma cruzi test implementation | Menitove JE, Leach-Bennett J, Sher G | 2012 | Transfusion | View Lessons learned from Trypanosoma cruzi test implementation | Blood operators | Other |
Mouse background and IVIG dosage are critical in establishing the role of inhibitory Fcgamma receptor for the amelioration of experimental ITP | Leontyev D, Katsman Y, Branch DR | 2012 | Blood | View Mouse background and IVIG dosage are critical in establishing the role of inhibitory Fcgamma receptor for the amelioration of experimental ITP | Researchers | Basic research |
Optimization of platelet concentrate quality: Application of proteomic technologies to donor management | Schubert P, Culibrk B, Karwal S, Slichter SJ, Devine DV | 2012 | J Proteomics | View Optimization of platelet concentrate quality: Application of proteomic technologies to donor management | Blood operators | Basic research |
Platelets in Thrombosis and Hemostasis: Old Topic with New Mechanisms | Wang Y, Andrews M, Yang Y, Lang S, Jin JW, Cameron-Vendrig A, Zhu G, Reheman A, Ni H | 2012 | Cardiovasc Hematol Disord Drug Targets | View Platelets in Thrombosis and Hemostasis: Old Topic with New Mechanisms | Health care providers | Basic research |
Antigens protected functional red blood cells by the membrane grafting of compact hyperbranched polyglycerols | Chapanian R, Constantinescu I, Brooks DE, Scott MD, Kizhakkedathu J | 2013 | J Vis Exp | View Antigens protected functional red blood cells by the membrane grafting of compact hyperbranched polyglycerols | Researchers | Basic research |
Cholesterol efflux in megakaryocyte progenitors suppresses platelet production and thrombocytosis | Murphy AJ, Bijl N, Yvan-Charvet L, Welch CB, Bhagwat N, Reheman A, Wang Y, Shaw JA, Levine RL, Ni H, Tall AR, Wang N | 2013 | Nat Med | View Cholesterol efflux in megakaryocyte progenitors suppresses platelet production and thrombocytosis | Researchers | Basic research |
Febrile and allergic transfusion reactions | Fung MK, Heddle NM | 2013 | Practical Transfusion Medicine, 4th edition | View Febrile and allergic transfusion reactions | Health care providers | Clinical research |
The rationale for platelet transfusion during cardiopulmonary bypass: an observational study | Zaffar N, Joseph A, Mazer CD, Nisenbaum R, Karkouti K, Tinmouth A, Peterson MD, Pavenski K, Callum J, Cserti-Gazdewich C, Shehata N | 2013 | Can J Anaesth | View The rationale for platelet transfusion during cardiopulmonary bypass: an observational study | Health care providers | Clinical research |
What to do with the queue? Reducing wait times for cancer care | Blake JT, Bolland D, Dawe I | 2013 | Case Studies in Health Policy and Management, 2nd Edition | View What to do with the queue? Reducing wait times for cancer care | Other | Other |
Activated platelets can deliver mRNA regulatory Ago2-microRNA complexes to endothelial cells via microparticles | Laffont B, Corduan A, Plé H, Duchez AC, Cloutier N, Boilard E, Provost P | 2013 | Blood | View Activated platelets can deliver mRNA regulatory Ago2-microRNA complexes to endothelial cells via microparticles | Researchers | Basic research |
Donor selection for recipient safety | Goldman M | 2013 | ISBT Sci Ser | View Donor selection for recipient safety | Health care providers | Clinical research |
ResearchUnit: Supporting evidence to change regulations regarding the storage of cryosupernatant plasma. | Sheffield W | 2013 | Blood.ca website | View ResearchUnit: Supporting evidence to change regulations regarding the storage of cryosupernatant plasma. | Other | Other |
The impact of prolonged storage of red blood cells on cancer survival | Kekre N, Mallick R, Allan D, Tinmouth A, Tay J | 2013 | PLoS One | View The impact of prolonged storage of red blood cells on cancer survival | Health care providers | Clinical research |
Microfluidic analysis of cellular deformability of normal and oxidatively-damaged red blood cells | Kwan JM, Quan Guo Q, Kyluik-Price DL, Ma H, Scott MD | 2013 | Am J Hematol | View Microfluidic analysis of cellular deformability of normal and oxidatively-damaged red blood cells | Researchers | Basic research |
The epidemiology of human T-cell lymphotropic virus types I and II in Canadian blood donors | O'Brien SF, Goldman M, Scalia V, Yi QL, Fan W, Xi G, Dines IR, Fearon MA | 2013 | Transfus Med | View The epidemiology of human T-cell lymphotropic virus types I and II in Canadian blood donors | Blood operators | Clinical research |
Exploring resource allocation and alternate clinic accessibility landscapes for improved blood donor turnout | Paez A, Esita J, Newbold KB, Heddle NM, Blake JT | 2013 | Appl Geogr | View Exploring resource allocation and alternate clinic accessibility landscapes for improved blood donor turnout | Blood operators | New or improved product or process |
Rapid removal of glycerol from frozen-thawed red blood cells | Lusianti RE, Benson JD, Acker JP, Higgins AZ | 2013 | Biotechnol Prog | View Rapid removal of glycerol from frozen-thawed red blood cells | Researchers | New or improved product or process |
Rejuvenation of ATP during storage does not reverse effects of the hypothermic storage lesion | Tchir JD, Acker JP, Holovati JL | 2013 | Transfusion | View Rejuvenation of ATP during storage does not reverse effects of the hypothermic storage lesion | Researchers | Basic research |
Risk factors and impact of major bleeding in critically ill patients receiving heparin thromboprophylaxis | Lauzier F, Arnold DM, Rabbat C, Heels-Ansdell D, Zarychanski R, Dodek P, Ashley BJ, Albert M, Khwaja K, Ostermann M, Skrobik Y, Fowler R, McIntyre L, Nates JL, Karachi T, Lopes RD, Zytaruk N, Finfer S, Crowther M, Cook D | 2013 | Intensive Care Med | View Risk factors and impact of major bleeding in critically ill patients receiving heparin thromboprophylaxis | Health care providers | Clinical research |
Drugs in ITP: Mechanisms of Action | Crow AR, Lazarus AH | 2013 | Immune Thrombocytopenia (ITP) | View Drugs in ITP: Mechanisms of Action | Researchers | Other |
Standardization of CD62P measurement: results of an international comparative study | Levin E, Serrano K, Devine DV, for the Biomedical Excellence for Safer Transfusion Collaborative | 2013 | Vox Sang | View Standardization of CD62P measurement: results of an international comparative study | Blood operators | Benchmarking and standard setting |
The use of the electronic (computer) cross-match | Reesink HW, Davis K, Wong J, Schwartz DW, Mayr WR, Devine DV, Georgsen J, Chiaroni J, Ferrera V, Roubinet F, Lin CK, O'Donovan B, Fitzgerald JM, Raspollini E, Villa S, Rebulla P, Makino S, Gounder D, Safwenberg J, Murphy MF, Staves J, Milkins C, Mercado TC, Illoh OC, Panzer S | 2013 | Vox Sang | View The use of the electronic (computer) cross-match | Blood operators | Benchmarking and standard setting |
Deja-vu all over again: using simulation to evaluate the impact of shorter shelf life for red blood cells at Hema-Quebec | Blake JT, Hardy M, Delage G, Myhal G | 2013 | Transfusion | View Deja-vu all over again: using simulation to evaluate the impact of shorter shelf life for red blood cells at Hema-Quebec | Blood operators | New or improved product or process |
Getting the Most Out of the Evidence for Transfusion Medicine | Stanworth SJ, Brunskill SJ, Doree C, Sally Hopewell S, Arnold D | 2013 | Practical Transfusion Medicine, 4th edition | View Getting the Most Out of the Evidence for Transfusion Medicine | Health care providers | Other |
Proteolytic modulation of factor Xa-antithrombin complex enhances fibrinolysis in plasma | Talbot K, Meixner SC, Pryzdial EL | 2013 | Biochim Biophys Acta | View Proteolytic modulation of factor Xa-antithrombin complex enhances fibrinolysis in plasma | Researchers | Basic research |
ResearchUnit: How does consolidation of blood production and distribution services impact hospitals? | Blake J | 2013 | Blood.ca website | View ResearchUnit: How does consolidation of blood production and distribution services impact hospitals? | Other | Other |
Biofilm formation by Staphylococcus capitis strains isolated from contaminated platelet concentrates | Greco-Stewart VS, Ali H, Kumaran D, Kalab M, Rood IG, de Korte D, Ramirez-Arcos S | 2013 | J Med Microbiol | View Biofilm formation by Staphylococcus capitis strains isolated from contaminated platelet concentrates | Blood operators | Basic research |
Predominant autoantibody response to GPIb/IX in a regulatory T-cell-deficient mouse model for immune thrombocytopenia | Nishimoto T, Satoh T, Simpson EK, Ni H, Kuwana M | 2013 | J Thromb Haemost | View Predominant autoantibody response to GPIb/IX in a regulatory T-cell-deficient mouse model for immune thrombocytopenia | Researchers | Basic research |
Quality of frozen transfusable plasma prepared from whole blood donations in Canada: An update | Sheffield WP, Bhakta V, Talbot K, Pryzdial ELG, Jenkins C | 2013 | Transfus Apher Sci | View Quality of frozen transfusable plasma prepared from whole blood donations in Canada: An update | Blood operators | Benchmarking and standard setting |
ResearchUnit: Platelets are Immune Cells! | Semple J | 2013 | Blood.ca website | View ResearchUnit: Platelets are Immune Cells! | Other | Other |
Synthesis of peptides and glycopeptides with polyproline II helical topology as potential antifreeze molecules | Corcilius L, Santhakumar G, Stone RS, Capicciotti CJ, Joseph S, Matthews JM, Ben RN, Payne RJ | 2013 | Bioorg Med Chem | View Synthesis of peptides and glycopeptides with polyproline II helical topology as potential antifreeze molecules | Researchers | Basic research |
Transfusion medicine data as product | Skeate RC | 2013 | Transfusion | View Transfusion medicine data as product | Researchers | Other |
Enhancing the Migration Ability of Mesenchymal Stromal Cells by Targeting the SDF-1/CXCR4 Axis | Marquez-Curtis LA, Janowska-Wieczorek A | 2013 | BioMed Res Int | View Enhancing the Migration Ability of Mesenchymal Stromal Cells by Targeting the SDF-1/CXCR4 Axis | Researchers | Basic research |
Innate and adaptive immunity in immune thrombocytopenia | Lazarus AH, Semple JW, Cines DB | 2013 | Semin Hematol | View Innate and adaptive immunity in immune thrombocytopenia | Researchers | Clinical research |
Chapter 5 - Platelet microRNAs | Provost P | 2013 | Platelets (Third Edition) | View Chapter 5 - Platelet microRNAs | Researchers | Other |
Evaluating Health Care Policy Decisions: Canadian Blood Services in Atlantic Canada | Blake JT, Rogerson M, Harris D | 2013 | Operations Research and Health Care Policy | View Evaluating Health Care Policy Decisions: Canadian Blood Services in Atlantic Canada | Other | New or improved product or process |
Fanconi anemia proteins interact with CtBP1 and modulate the expression of the Wnt antagonist Dickkopf-1 | Huard CC, Tremblay CS, Helsper K, Delisle MC, Schindler D, Levesque G, Carreau M | 2013 | Blood | View Fanconi anemia proteins interact with CtBP1 and modulate the expression of the Wnt antagonist Dickkopf-1 | Researchers | Basic research |
The effect of rituximab on vaccine responses in patients with immune thrombocytopenia | Nazi I, Kelton JG, Larche M, Snider DP, Heddle NM, Crowther MA, Cook RJ, Tinmouth AT, Mangel J, Arnold DM | 2013 | Blood | View The effect of rituximab on vaccine responses in patients with immune thrombocytopenia | Health care providers | Clinical research |
Hemolytic anemia due to passenger lymphocyte syndrome in solid malignancy patients treated with allogeneic natural killer cell products | Skeate R, Singh C, Cooley S, Geller M, Northouse J, Welbig J, Slungaard A, Miller J, McKenna D | 2013 | Transfusion | View Hemolytic anemia due to passenger lymphocyte syndrome in solid malignancy patients treated with allogeneic natural killer cell products | Health care providers | Clinical research |
Is Cytomegalovirus Testing of Blood Products Still Needed for Hematopoietic Stem Cell Transplant Recipients in the Era of Universal Leukoreduction? | Kekre N, Tokessy M, Mallick R, McDiarmid S, Huebsch L, Bredeson C, Allan D, Tay J, Tinmouth A, Sheppard D | 2013 | Biol Blood Marrow Transplant | View Is Cytomegalovirus Testing of Blood Products Still Needed for Hematopoietic Stem Cell Transplant Recipients in the Era of Universal Leukoreduction? | Health care providers | Clinical research |
New RHCE variant alleles encoding the D– – phenotype | Ochoa-Garay G, Moulds JM, Cote J, Kresie L, Garaizar A, Goldman M, Wynn P | 2013 | Transfusion | View New RHCE variant alleles encoding the D– – phenotype | Health care providers | Clinical research |
Asthma associated with incontinentia pigmenti and fanconi anemia: variable airflow limitation without cellular bronchitis | Dasgupta A, Sanaee MS, Bauer CM, Botelho FM, Arnold DM, Stampfli MR, Nair P | 2013 | Chest | View Asthma associated with incontinentia pigmenti and fanconi anemia: variable airflow limitation without cellular bronchitis | Health care providers | Clinical research |
Expression screening of bacterial libraries of recombinant alpha-1 proteinase inhibitor variants for candidates with thrombin inhibitory capacity | Bhakta V, Gierczak RF, Sheffield WP | 2013 | J Biotechnol | View Expression screening of bacterial libraries of recombinant alpha-1 proteinase inhibitor variants for candidates with thrombin inhibitory capacity | Researchers | Basic research |
Impact of changes to policy for Mexican risk travel on Canadian blood donor deferrals | O'Brien SF, Uzicanin S, Choquet K, Yi QL, Fan W, Goldman M | 2013 | Blood Transfus | View Impact of changes to policy for Mexican risk travel on Canadian blood donor deferrals | Blood operators | New or improved product or process |